visiongain Logo.png
NASH Treatment & Therapeutics market is projected to grow at a CAGR of 38.6% by 2033: Visiongain
13 sept. 2023 09h04 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled NASH Treatment & Therapeutics Market Report 2023-2033: Forecasts by Product Type (Vitamin E and Pioglitazone, Ocaliva, Elafibranor, Selonsertib,...